SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media (DJT) is actively trending following news of its definitive all-stock merger with fusion energy firm TAE Technologies, valued at over $6 billion. This significant pivot into the clean energy sector for AI power is sparking intense debate among the community, with many anticipating a major short squeeze while others view it as another speculative "pump" or "grift".

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is surging amid intense community anticipation of an imminent executive order to reclassify cannabis to Schedule III. Investors are widely discussing the potential elimination of punitive 280E taxes, which would significantly boost profitability and pave the way for institutional capital and uplisting for U.S. multi-state operators, marking a historic shift for the sector.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital (MARA) is trending amid intense debate over its valuation and correlation with Bitcoin's volatile price movements, with many noting its underperformance compared to other crypto miners. The community is sharply divided; bears highlight consistent dilution, perceived poor management, and insider selling, while bulls point to high short interest and deep undervaluation as a potential buying opportunity, especially if the company successfully pivots into AI/HPC.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is a major discussion point as it solidifies its role as a leader in AI infrastructure, propelled by new partnerships and substantial revenue growth targets for its advanced server solutions. However, ongoing volatility sparks polarized community views, with many citing deep undervaluation and market manipulation amidst positive sector news, while others express frustration over the stock's performance despite its strong AI narrative.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron (MU) is trending after delivering a blockbuster earnings report and exceptionally strong guidance, significantly surpassing analyst expectations. This performance is largely driven by robust demand for AI-driven memory, with the company indicating High-Bandwidth Memory (HBM) is fully committed through 2026. The community is actively discussing impressive margin expansion, potential new all-time highs, and numerous analyst price target increases, which is bolstering optimism for the broader AI sector.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing notable volatility, driven by a California court ruling challenging its 'Full Self-Driving' marketing claims and the broader market's reaction to economic data. The community remains sharply divided, with bulls anticipating a swift rebound towards new highs based on Elon Musk's long-term vision, while bears highlight regulatory hurdles and valuation concerns. This intense divergence in sentiment continues to fuel active discussion surrounding the company's technology and market trajectory.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a significant surge following an earnings beat that highlighted its strategic positioning to meet the escalating power demands of AI data centers. Community discussions are heavily focused on whether the company's natural gas-powered fuel cell technology presents a compelling immediate solution in this booming sector, drawing comparisons to peers. While some investors remain cautious due to historical performance and past dilution, many view this as a pivotal moment for FCEL to capitalize on the AI infrastructure buildout.

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Athira Pharma Inc

Athira Pharma is trending with strong momentum after announcing an exclusive license for a Phase 3 breast cancer drug candidate and securing substantial new financing from institutional investors. This strategic pivot into oncology, combined with the stock's relatively low float, is driving community discussions focused on significant upside potential and a possible short squeeze.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is currently trending amid widespread anticipation of an imminent Executive Order to reclassify cannabis to Schedule III, a move seen by many as a monumental shift for the entire sector. The community is buzzing with speculation about a potential short squeeze, significant institutional investment, and the elimination of 280E tax burdens, while some express caution about a 'sell the news' event or the direct impact on Canadian operators. This potential regulatory change is widely viewed as a foundational step to unlock new opportunities and reshape the cannabis market.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as investors and the community keenly await its upcoming earnings report, with sentiment divided between anticipation for a turnaround driven by strong brand initiatives and upcoming major sports events, and concerns over slowing demand in key international markets. The market is actively debating whether its "Win Now" strategy can overcome competitive pressures and margin challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Consensus Recommendation of "Buy" from Analysts

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) has earned an average recommendation of "Buy" from the nine analysts that are covering the company, MarketBeat.com reports. One analyst has...

Spyre Therapeutics (NASDAQ:SYRE) Hits New 52-Week High - Should You Buy?

Spyre Therapeutics (NASDAQ:SYRE) Sets New 12-Month High - Here's What Happened...

Spyre Therapeutics (NASDAQ:SYRE) Trading Up 7.2% - Still a Buy?

Spyre Therapeutics (NASDAQ:SYRE) Trading Up 7.2% - What's Next...

Spyre Therapeutics (NASDAQ:SYRE) CEO Cameron Turtle Sells 15,000 Shares

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) CEO Cameron Turtle sold 15,000 shares of Spyre Therapeutics stock in a transaction dated Monday, December 1st. The stock was sold at an...

Spyre Therapeutics (NASDAQ:SYRE) Sets New 12-Month High on Analyst Upgrade

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 52-Week High on Analyst Upgrade...

Spyre Therapeutics (NASDAQ:SYRE) Upgraded by Jones Trading to Buy Rating

Jones Trading upgraded shares of Spyre Therapeutics from a "hold" rating to a "buy" rating and set a $64.00 target price for the company in a research note on Monday...

Spyre Therapeutics, Inc. $SYRE Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH lessened its holdings in Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) by 9.2% in the second quarter, according to the company in its most...

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 52-Week High - Here's What Happened

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 1-Year High - Time to Buy...

Foresite Capital Management VI LLC Makes New Investment in Spyre Therapeutics, Inc. $SYRE

Foresite Capital Management VI LLC acquired a new stake in Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and...

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Average Recommendation of "Buy" from Brokerages

Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) have earned an average rating of "Buy" from the eight ratings firms that are covering the stock, MarketBeat Ratings reports. One...

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Spyre Therapeutics Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

SYRE
Aeglea BioTherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SYRE News

SYREAeglea BioTherapeutics Inc